Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$872K Buy
4,475
+444
+11% +$92K 0.03% 122
2026
Q1
$905K Buy
4,031
+169
+4% +$42.1K 0.05% 113
2025
Q4
$930K Buy
3,862
+3,807
+6,922% +$974K 0.07% 103
2025
Q3
$15.1K Sell
55
-26
-32% -$7.1K ﹤0.01% 262
2025
Q2
$20.9K Sell
81
-43
-35% -$10.3K ﹤0.01% 196
2025
Q1
$27.8K Buy
124
+68
+121% +$15.9K ﹤0.01% 186
2024
Q4
$12.8K Buy
56
+12
+27% +$2.89K ﹤0.01% 231
2024
Q3
$10.7K Sell
44
-16
-27% -$3.58K ﹤0.01% 250
2024
Q2
$11.5K Buy
+60
New +$12.2K ﹤0.01% 254

Other funds holding RMD

Global X Japan's RMD Position: Q2 2026 in Review

Global X Japan increased its ResMed (RMD) stake by 11% in Q2 2026, buying an estimated $92K and bringing the position to 4,475 shares worth $872K. The position accounts for 0.03% of the portfolio, ranked #122.

Global X Japan first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $930K in Q4 2025. 141 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Global X Japan held 4,475 shares of ResMed worth $872K as of Q2 2026.
  • Global X Japan bought 444 ResMed shares in Q2 2026, an estimated $92K.
  • ResMed made up 0.03% of Global X Japan's portfolio in Q2 2026, its #122 holding.
  • Global X Japan first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
  • Global X Japan's ResMed position peaked at $930K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Global X Japan's 13F filing for Q2 2026, filed 14 Jul 2026.